Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 61 to 64 of 64 entries
Sorted by: Best Match Show Resources per page
Effect of food on the pharmacokinetics of dronabinol oral solution versus dronabinol capsules in healthy volunteers.

Clinical pharmacology : advances and applications

Oh DA, Parikh N, Khurana V, Cognata Smith C, Vetticaden S.
PMID: 28138268
Clin Pharmacol. 2017 Jan 11;9:9-17. doi: 10.2147/CPAA.S119676. eCollection 2017.

Dronabinol is a pharmaceutical tetrahydrocannabinol originally developed as an oral capsule. A dronabinol oral solution was recently approved, and the effects of food on absorption and bioavailability of the oral solution versus capsules were compared in an open-label, single-dose,...

Cite
Oh DA, Parikh N, Khurana V, et al. Effect of food on the pharmacokinetics of dronabinol oral solution versus dronabinol capsules in healthy volunteers. Clin Pharmacol. 2017;9:9-17doi: 10.2147/CPAA.S119676.
Oh, D. A., Parikh, N., Khurana, V., Cognata Smith, C., & Vetticaden, S. (2017). Effect of food on the pharmacokinetics of dronabinol oral solution versus dronabinol capsules in healthy volunteers. Clinical pharmacology : advances and applications, 99-17. https://doi.org/10.2147/CPAA.S119676
Oh, D Alexander, et al. "Effect of food on the pharmacokinetics of dronabinol oral solution versus dronabinol capsules in healthy volunteers." Clinical pharmacology : advances and applications vol. 9 (2017): 9-17. doi: https://doi.org/10.2147/CPAA.S119676
Oh DA, Parikh N, Khurana V, Cognata Smith C, Vetticaden S. Effect of food on the pharmacokinetics of dronabinol oral solution versus dronabinol capsules in healthy volunteers. Clin Pharmacol. 2017 Jan 11;9:9-17. doi: 10.2147/CPAA.S119676. eCollection 2017. PMID: 28138268; PMCID: PMC5238805.
Copy Download .nbib Format: NLM
Tetrahydrocannabinol fails to reduce hair pulling or skin picking: results of a double-blind, placebo-controlled study of dronabinol.

International clinical psychopharmacology

Grant JE, Valle S, Chesivoir E, Ehsan D.
PMID: 34825898
Int Clin Psychopharmacol. 2022 Jan 01;37(1):14-20. doi: 10.1097/YIC.0000000000000382.

Body-focused repetitive behaviors (BFRBs) such as trichotillomania and skin picking disorder are associated with decreased self-esteem and poor quality of life. The objective of this study was to evaluate dronabinol, a cannabinoid agonist, for the reduction of BFRB symptoms....

Cite
Grant JE, Valle S, Chesivoir E, et al. Tetrahydrocannabinol fails to reduce hair pulling or skin picking: results of a double-blind, placebo-controlled study of dronabinol. Int Clin Psychopharmacol. 2022;37(1):14-20doi: 10.1097/YIC.0000000000000382.
Grant, J. E., Valle, S., Chesivoir, E., & Ehsan, D. (2022). Tetrahydrocannabinol fails to reduce hair pulling or skin picking: results of a double-blind, placebo-controlled study of dronabinol. International clinical psychopharmacology, 37(1), 14-20. https://doi.org/10.1097/YIC.0000000000000382
Grant, Jon E, et al. "Tetrahydrocannabinol fails to reduce hair pulling or skin picking: results of a double-blind, placebo-controlled study of dronabinol." International clinical psychopharmacology vol. 37,1 (2022): 14-20. doi: https://doi.org/10.1097/YIC.0000000000000382
Grant JE, Valle S, Chesivoir E, Ehsan D. Tetrahydrocannabinol fails to reduce hair pulling or skin picking: results of a double-blind, placebo-controlled study of dronabinol. Int Clin Psychopharmacol. 2022 Jan 01;37(1):14-20. doi: 10.1097/YIC.0000000000000382. PMID: 34825898.
Copy Download .nbib Format: NLM
Neuropathic itch treated with oral cannabinoids: A case series.

JAAD case reports

Morin CB, Raef HS, Elmariah SB.
PMID: 34692966
JAAD Case Rep. 2021 Sep 20;17:38-42. doi: 10.1016/j.jdcr.2021.09.006. eCollection 2021 Nov.

No abstract available.

Cite
Morin CB, Raef HS, Elmariah SB. Neuropathic itch treated with oral cannabinoids: A case series. JAAD Case Rep. 2021;17:38-42doi: 10.1016/j.jdcr.2021.09.006.
Morin, C. B., Raef, H. S., & Elmariah, S. B. (2021). Neuropathic itch treated with oral cannabinoids: A case series. JAAD case reports, 1738-42. https://doi.org/10.1016/j.jdcr.2021.09.006
Morin, Catherine Besner, et al. "Neuropathic itch treated with oral cannabinoids: A case series." JAAD case reports vol. 17 (2021): 38-42. doi: https://doi.org/10.1016/j.jdcr.2021.09.006
Morin CB, Raef HS, Elmariah SB. Neuropathic itch treated with oral cannabinoids: A case series. JAAD Case Rep. 2021 Sep 20;17:38-42. doi: 10.1016/j.jdcr.2021.09.006. eCollection 2021 Nov. PMID: 34692966; PMCID: PMC8517709.
Copy Download .nbib Format: NLM
Cannabis-Based Medicines and Medical Cannabis for Chronic Neuropathic Pain.

CNS drugs

Petzke F, Tölle T, Fitzcharles MA, Häuser W.
PMID: 34802112
CNS Drugs. 2022 Jan;36(1):31-44. doi: 10.1007/s40263-021-00879-w. Epub 2021 Nov 21.

Neuropathic pain represents a broad category of pain syndromes that include a wide variety of peripheral and central disorders. The overall prevalence of neuropathic pain in the general population is reported to be between 7 and 10%. Management of...

Cite
Petzke F, Tölle T, Fitzcharles MA, et al. Cannabis-Based Medicines and Medical Cannabis for Chronic Neuropathic Pain. CNS Drugs. 2021;36(1):31-44doi: 10.1007/s40263-021-00879-w.
Petzke, F., Tölle, T., Fitzcharles, M. A., & Häuser, W. (2022). Cannabis-Based Medicines and Medical Cannabis for Chronic Neuropathic Pain. CNS drugs, 36(1), 31-44. https://doi.org/10.1007/s40263-021-00879-w
Petzke, Frank, et al. "Cannabis-Based Medicines and Medical Cannabis for Chronic Neuropathic Pain." CNS drugs vol. 36,1 (2022): 31-44. doi: https://doi.org/10.1007/s40263-021-00879-w
Petzke F, Tölle T, Fitzcharles MA, Häuser W. Cannabis-Based Medicines and Medical Cannabis for Chronic Neuropathic Pain. CNS Drugs. 2022 Jan;36(1):31-44. doi: 10.1007/s40263-021-00879-w. Epub 2021 Nov 21. PMID: 34802112.
Copy Download .nbib Format: NLM
Showing 61 to 64 of 64 entries